Literature DB >> 24703235

Predictive accuracy of Edinburgh postnatal depression scale assessment during pregnancy for the risk of developing postpartum depressive symptoms: a prospective cohort study.

J L Meijer1, C Beijers, M G van Pampus, T Verbeek, R P Stolk, J Milgrom, C L H Bockting, H Burger.   

Abstract

OBJECTIVE: To investigate whether the 10-item Edinburgh Postnatal Depression Scale (EPDS) administered antenatally is accurate in predicting postpartum depressive symptoms, and whether a two-item EPDS has similar predictive accuracy.
DESIGN: Prospective cohort study.
SETTING: Obstetric care in the Netherlands. POPULATION: One thousand six hundred and twenty women from the general population.
METHODS: Mean values, area under the receiver operating characteristics curve (AUC), sensitivity, specificity and predictive values of antenatal EPDS for the likelihood of developing postpartum depressive symptoms were calculated. Analyses were repeated for each trimester, several cut-off values and a two-item EPDS (low mood and anhedonia). MAIN OUTCOME MEASURES: Postpartum depressive symptoms, defined as EPDS score≥10.
RESULTS: Mean EPDS scores were significantly higher during each trimester in women with postpartum depressive symptoms than in those without the symptoms (P<0.001). Using the prevailing cut-off (≥13), the AUC was reasonable (0.74), sensitivity was 16.8% (95% CI 11.0-24.1), positive predictive value was 41.8% (95% CI 28.7-55.9), specificity was 97.8% (95% CI 97.0-98.5) and negative predictive value was 92.7% (95% CI 91.3-94.0). Using a lower cut-off value (≥5), sensitivity was 70.8% (95% CI 62.4-78.3) and specificity was 65.4% 4 (95% CI 62.9-67.8), but positive predictive value was low (15.9%, 95% CI 13.1-19.0). Negative predictive value was exceedingly high at 96.0% (95% CI 94.6-97.2). Results were similar during the second and third trimester. The predictive accuracy of the two-item EPDS appeared inferior.
CONCLUSIONS: The EPDS was not sufficiently accurate in predicting risk of postpartum depressive symptoms. Nevertheless, when using the ≥5 cut-off value, it may be adequate for initial screening, followed by further assessments and possibly antenatal intervention when positive. Furthermore, when negative, women may be reassured that postpartum depressive symptoms are unlikely. A two-item version showed poor predictive accuracy.
© 2014 Royal College of Obstetricians and Gynaecologists.

Entities:  

Keywords:  Antenatal depression; postpartum depression; predictive accuracy

Mesh:

Year:  2014        PMID: 24703235     DOI: 10.1111/1471-0528.12759

Source DB:  PubMed          Journal:  BJOG        ISSN: 1470-0328            Impact factor:   6.531


  23 in total

1.  Sleep disturbances and depressive and anxiety symptoms during pregnancy: associations with delivery and newborn health.

Authors:  Hilla Peltonen; E Juulia Paavonen; Outi Saarenpää-Heikkilä; Tero Vahlberg; Tiina Paunio; Päivi Polo-Kantola
Journal:  Arch Gynecol Obstet       Date:  2022-04-24       Impact factor: 2.344

2.  Racial Differences in the Risk of Prenatal Depression Among Women Experiencing Childhood and Adult Stressors.

Authors:  Melissa Goldin Evans; Katherine P Theall; Chanaye Jackson; Stacy Drury
Journal:  Matern Child Health J       Date:  2021-12-01

3.  Cortisol response to the Trier Social Stress Test in pregnant women at risk for postpartum depression.

Authors:  Kristina M Deligiannidis; Aimee R Kroll-Desrosiers; Abby Svenson; Nina Jaitly; Bruce A Barton; Janet E Hall; Anthony J Rothschild
Journal:  Arch Womens Ment Health       Date:  2016-03-07       Impact factor: 3.633

4.  Peripartum neuroactive steroid and γ-aminobutyric acid profiles in women at-risk for postpartum depression.

Authors:  Kristina M Deligiannidis; Aimee R Kroll-Desrosiers; Shunyan Mo; Hien P Nguyen; Abby Svenson; Nina Jaitly; Janet E Hall; Bruce A Barton; Anthony J Rothschild; Scott A Shaffer
Journal:  Psychoneuroendocrinology       Date:  2016-05-09       Impact factor: 4.905

5.  White matter integrity in medication-free women with peripartum depression: a tract-based spatial statistics study.

Authors:  Michelle Silver; Constance M Moore; Vanessa Villamarin; Nina Jaitly; Janet E Hall; Anthony J Rothschild; Kristina M Deligiannidis
Journal:  Neuropsychopharmacology       Date:  2018-02-05       Impact factor: 7.853

6.  Acetaminophen use in pregnancy: Examining prevalence, timing, and indication of use in a prospective birth cohort.

Authors:  Gretchen Bandoli; Kristin Palmsten; Christina Chambers
Journal:  Paediatr Perinat Epidemiol       Date:  2019-11-07       Impact factor: 3.980

7.  The association between labour epidural analgesia and postpartum depressive symptoms: a longitudinal cohort study.

Authors:  Allana Munro; Ronald B George; Sean P Mackinnon; Natalie O Rosen
Journal:  Can J Anaesth       Date:  2021-01-06       Impact factor: 6.713

8.  Peripartum depression: Does risk versus diagnostic status impact mother-infant bonding and perceived social support?

Authors:  Megan M Hare; Aimee Kroll-Desrosiers; Kristina M Deligiannidis
Journal:  Depress Anxiety       Date:  2020-12-07       Impact factor: 6.505

9.  Anxiety and depression during pregnancy in Central America: a cross-sectional study among pregnant women in the developing country Nicaragua.

Authors:  T Verbeek; R Arjadi; J J Vendrik; H Burger; M Y Berger
Journal:  BMC Psychiatry       Date:  2015-11-17       Impact factor: 3.630

10.  Impact of a high Edinburgh Postnatal Depression Scale score on obstetric and perinatal outcomes.

Authors:  Pathmila Navaratne; Xin Y Foo; Sailesh Kumar
Journal:  Sci Rep       Date:  2016-09-23       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.